Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Argos Therapeutics (Group)

Argos is an immunotherapy company developing new treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The Company has generated multiple platform technologies and a diverse pipeline of products based on its expertise in the biology of dendritic cells - the master switch that turns the immune system on or off. *


Period Start 2005-04-06 existent
  Predecessor Merix Bioscience Inc.
Products Industry Arcelis™ technology platform
  Industry 2 AGS-003 (Argos Therapeutics)
Region Region Durham, NC
  Country United States (USA)
  Street 4233 Technology Drive
  City 27704 Durham, NC
  Tel +1-919-287-6300
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: 
Record changed: 2018-10-31


Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px

More documents for Argos Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Global Partnering Four Events One Price 650x80

» top